Diagnostic accuracy of the maximal systolic acceleration for detection of peripheral arterial disease in patients with diabetes-related foot ulceration.

Diagnostic accuracy of the maximal systolic acceleration for detection of peripheral arterial disease in patients with diabetes-related foot ulceration. - DIAMACC study (DIAbetes Maximal ACCeleration)

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON51397

Enrollment

198

Registered

2022-07-22

Start date

2023-11-27

Completion date

Unknown

Last updated

2025-12-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Peripheral arterial disease Poor blood flow in the legs

Interventions

Duplex ultrasound with measurement of maximal systolic acceleration

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - 18 years or older. - Diabetes Mellitus in medical history. - Presenting with a diabetic foot ulcer with initiation of a new diagnostic carepath

Exclusion criteria

Exclusion criteria: Lacking capacity to consent to inclusion.

Design outcomes

Primary

Measure	Time frame
Sensitivity and specificity including their derivates PLR and NLR in the diagnostic accuracy of the ACCmax for peripheral arterial disease in the diabetic foot.	—

Secondary

Measure	Time frame
* Correlation patient demographics and comorbidities with diagnostic accuracy * Comparison of ACCmax with sensitivity/specificity of current bedside tests * Collecting follow-up data for prognostic patient group evaluation, such as wound healing, revascularisation probability, complications and mortality.	—

Countries

Netherlands

Contacts

Public ContactS.A. Willems

Leids Universitair Medisch Centrum

S.A.Willems@lumc.nl070 210 4359

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)